Request Deal Involvement
NewAmsterdam Pharma went public via a SPAC merger with Frazier Lifesciences Acquisition in a $326m deal.
Identify your role
Select the side you represented in this transaction, and provide your current job title.
Service Providers
financial advisors
Credit Suisse
legal advisors to financial advisors
Kirkland & Ellis
legal advisors
Goodwin Procter
financial advisors
Leerink Partners
financial advisors
William Blair & Co
financial advisors
Jefferies & Company
financial advisors
Lincoln International
legal advisors
Campbells
legal advisors
Houthoff
legal advisors
Covington & Burling
financial advisors
Moelis & Co
pr advisors
Precision AQ
financial advisors
Leerink Partners
pr advisors
Spectrum Science
legal advisors
NautaDutilh
legal advisors to financial advisors
Latham & Watkins
or
Principals
bidder
FRAZIER LIFESCIENCES ACQUISITION CORPOARTION
bidder
FRAZIER HEALTHCARE PARTNERS
target
NEWAMSTERDAM PHARMA HOLDING
bidder
BAIN CAPITAL LIFE SCIENCES
Principals or Service Provider not listed?Add missing Service Provider or Principal
Enter your Job Title on this deal
This title will appear on your profile next to this deal involvement.
To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:
All rights reserved. Copyright © 2025 Datasite